MOUNT ARLINGTON, N.J., Aug. 8, 2011 /PRNewswire-iReach/ -- Semantelli, a New Jersey based start-up, announced today the release of Facebook AETracker- a unique solution to help pharmaceutical companies maintain Facebook pages after the August 15th deadline imposed by the social networking giant. In May this year, Facebook announced it will enable public feedback and comments to encourage bidirectional dialogue on pages created by pharmaceutical companies, ending an exclusive privilege it had given pharma since facebook launched its business pages.
Facebook AETracker helps pharma companies track Adverse Drug Reactions and Product Misinformation in user comments on company sponsored Facebook pages in real-time with additional workflow to report them to FDA.
"Our ability to track Adverse Events, Product Misinformation and other potential threats real-time in Facebook, Twitter and other social media channels should make FDA happy. This allows pharma companies stay on Facebook, and at the same time frees them to further explore the power of social media without waiting for guidelines or fearing regulatory impacts. Social Media is just another channel. We should treat it as such. It can play a major role in improving health outcome." said Siva Nadarajah CEO of Semantelli.
In addition to identifying Adverse Events and Misinformation, the Semantelli product will also spot possible threats and hacks that may impact the reputation of a company.
In July of this year, pharma giant Pfizer's Facebook page was hacked by a group called Script Kiddies. They posted anti-Pfizer messages and angry language aiming at the company. The UK based group also added unflattering profile images to the page and posted links to news articles critical of the firm. The group also claimed responsbility for the Fox News hack last month.
"This is a natural addition to our enterprise reputation platform. Recent hack on Pfizer's Facebook page is a clear example that tools that can spot threats are necessary to augment human moderation. Our offering is an end-to-end real-time solution that combines technology with traditional moderation" added Siva Nadarajah.
Semantelli is the leader in Semantic Web based enterprise listening solutions for the global life sciences industry. Companies use Semantelli's compliance sensitive solutions to monitor social media, web and internal unstructured data sources to find previously unknown early warnings, threats and opportunities. Semantelli customers have found immediate ROI, ranging from spotting threats, new trends, targeted promotions and engaging doctors who have shown signs of switching to competitor brands. Semantelli is a privately held start-up headquartered in Mount Arlington, NJ. For more information visit http://www.semantelli.com/pharma
Media Contact: Siva Nadarajah Semantelli Corp., 1-908-547-0205, email@example.com
|SOURCE Semantelli Corp.|
Copyright©2010 PR Newswire.
All rights reserved